Category: Health

Lahore (Muhammad Yasir) As a research-driven pharmaceutical company, Getz Pharma takes an active role in supporting advanced scientific studies that can help patients and healthcare professionals in dealing with life-threatening diseases. This time, Getz Pharma is proud to launch Pakistan’s First Metabesity Guideline in collaboration with leading medical societies of Pakistan.

The leading medical societies include Pakistan Cardiac Society, Pakistan Society of Nephrology, Pakistan Society of Neurology, Pakistan Endocrine Society, and Pakistan Society of Gastroenterology & G.I. Endoscopy.

Pakistan is amongst the top ten countries in terms of obesity, with individuals at a higher risk of metabolic disorders or Metabesity. The term Metabesity can be defined as a combination of metabolic diseases that include diabetes, obesity, metabolic syndrome, cardiovascular disease, neurodegenerative disorders, and accelerated aging.

At present, the majority of healthcare professionals take a one-sided approach to treat patients who are obese, disregarding various underlying medical conditions that the patient might be currently dealing with. This impacts the health of the patient in the long run, who is not being screened by other medical specialists. Hence, there is a dire need to treat patients holistically rather than for one specific medical condition.

However, since Metabesity is a relatively new term, there is not enough scientific research data available for healthcare professionals to use while treating patients. “Recent data of Pakistan suggests the need for preventive interventions to manage the obesogenic state of the country, which can be achieved with the help of effective practice guidelines and procedures. GI problems in diabetes are common but not commonly recognized in clinical practice,” says Dr. Saad Khalid Niaz- Metabesity, working group member.

“Metabesity is a complex medical condition, which has its roots in contrasting medical conditions. We need to come to a consensus about how to decrease the incidence of Metabesity by preventing it and taking a multi-disciplinary approach to manage it,” says Dr. S. Abbas Raza, corresponding author of Metabesity Guideline.

Getz Pharma’s main objective behind this initiative was to bring these five medical societies under a single platform and formulate a uniform diagnosis, treatment, and parameters that are specific to the Pakistani population. Further, the Metabesity guidelines include recommendations from different medical specialists along with a list of preventive strategies which patients and healthcare professionals can use to successfully treat Metabesity.

By launching Pakistan’s First Metabesity Guidelines, Getz Pharma has taken the first step to start a silo-breaking conversation that will help address local complications of obesity. Appreciating Getz Pharma’s efforts, Dr. Abdul Karim Zarkoon -President, Pakistan Society of Nephrology says, “Getz Pharma has always come up with solutions to the deteriorating health of our people. And this time again under the banner of Metabesity Project, they are helping to organize, connect, energize, and enabling us to contribute to the audacious goals of substantially reducing the burden of chronic disease.”

 

LAHORE: Punjab Emergency Service Department (PESD) Director General Dr Rizwan Naseer Thursday regularized 48 rescue officials, including 39 safety officers, eight control room incharges and one training instructor on the recommendations of the scrutiny committee. The DG PESD congratulated officers on their regularization and said that this was an acknowledgement of their services. He hoped that this step would provide them with greater motivation and a sense of safety to work with greater commitment and devotion.

 

COPENHAGEN: The World Health Organization on Thursday said over two months of declining Covid cases in Europe had come to an end, warning a new wave would come “unless we remain disciplined. ” “Last week, the number of cases rose by 10 percent, driven by increased mixing, travel, gatherings and easing of social restrictions,” WHO”s regional director for Europe Hans Kluge told a press conference.

 

ISLAMABAD: China on Wednesday handed over 200 mobile oxygen concentrators to Pakistan in an effort to help the country’s battle against COVID-19 pandemic. In a ceremony held here, Chinese Ambassador, Nong Rong handed over the oxygen concentrators to National Disaster Management Authority (NDMA) Chairman Lieutenant General Akhter Nawaz Satti, said media release. The ceremony was attended by officials from Chinese embassy, health and foreign affairs ministries and NDMA. The NDMA chairman on behalf of people and the government of Pakistan thanked the Chinese side for donation of oxygen concentrators. Speaking on the occasion Ambassador Nong Rong said China Pakistan relations were growing stronger with the passage of time.

 

WASHINGTON: Pakistan is set to receive 2.5 million doses of the Moderna vaccine from the United States, White House spokesperson Jen Psaki has said. The shipment is part of President Joe Biden”s commitment to play a leading role in ending the coronavirus pandemic everywhere, she told her regular briefing on Monday. Last week, the US president had announced his plans to allocate 75 per cent of unused Covid-19 vaccines through the UN-backed Covax global vaccine sharing programme. The White House unveiled the allocation for sharing the first 25 million doses with the world. Of the first tranche of 25 million doses, the White House says about 19 million will go to Covax, with approximately 6 million for South and Central America, 7 million for Asia, and 5 million for Africa. The doses mark a substantial — and immediate — boost to the lagging Covax effort, which to date has shared just 76 million doses with needy countries.

WELLINGTON: New Zealand researchers have created a weight-loss device that uses magnets to clamp a patient”s jaw together — hailing it as a new tool against obesity despite critics likening it to an instrument of medieval torture. The “world-first” innovation involves a dentist fitting magnets and locking bolts to the patient”s upper and lower molars, allowing the jaws to open only two millimetres. Lead researcher Paul Brunton, from the University of Otago”s school of health sciences, said this restricted the user to a liquid diet without limiting breathing or speech. “It is a non-invasive, reversible, economical and attractive alternative to surgical procedures,” he said. “The fact is, there are no adverse consequences with this device. ” The researchers added they had “developed a world-first weight-loss device to help fight the global obesity epidemic”. In a paper published in the British Dental journal this month, they said seven women each lost an average of 6.36 kilograms (1.0 stone) during a two-week trial with the device, called the DentalSlim Diet Control. It found the patients experienced some initial discomfort but generally found the device “tolerable”. Unlike jaw wiring, which was a popular way for restricting people to liquid diets in the 1980s, the DentalSlim has an emergency release in case the patient vomits or has a panic attack. The release was not used by any patient during the two-week trial, although one woman admitted cheating the liquid diet by melting chocolate to get a sugary hit. The invention generated a strong response on social media, with many users accusing the researchers of shaming fat people and questioning the ethics of the trial.

Live #LifeUninterrupted with Molped Hygiene Shield

Lahore (Muhammad Yasir) Hayat Kimya’s sanitary pad brand, Molped, has been providing women across the globe with innovative products and solutions for more than 2 decades. Now, in 2021, the company has also introduced Molped in Pakistan with famous Turkish star Esra Bilgic as the face of the brand.

Monthly periods pose different challenges for women in Pakistan; one of the biggest concerns is the fear of a poor-quality product that causes rash and irritation among other problems. This unfortunately interrupts and disrupts the everyday life of Pakistani women. Girls and women in Pakistan should be provided with an environment along with quality products that allow them to manage their menstruation with ease and dignity.

After extensive research on the subject and evaluation of the needs of Pakistani women, Molped has launched Hygiene Shield Portfolio in Pakistan which has been specifically designed for Pakistani women. Hygiene Shield, an anti-germ protection layer, is a first in Pakistan. It provides superior absorption, odor protection, and long hours of hygiene to Pakistani women; ensuring they don’t miss out on life and continue as per normal without any interruptions even during their periods. In short, Molped Hygiene Shield will enable women to live #LifeUninterrupted!

The brand ambassador of Molped Pakistan, Esra Bilgic has expressed her pleasure on joining this campaign and as well as her confidence in hygiene shield by saying, “Molped Hygiene Shield is my ultimate hygiene partner! It doesn’t only protect me but also gives me long hours of hygiene! It is finally time to say goodbye to bad odor! I am sure my fellow Pakistani women will agree with me and live #LifeUninterrupted thanks to it.”

Tolga Arslan, CEO of Hayat Kimya Pakistan, while announcing the launch of Molped in Pakistan, said, “We are excited to bring innovation in the form of Molped Hygiene Shield to Pakistan; with its superior product performance, including fast absorption and anti-odor feature, Molped will ensure long hours of hygiene and better product experience versus competitors. Our confidence lies in the quality of our product and we are hopeful that consumers will love it as much as Esra does!”

To get more information about Molped Hygiene Shield, visit our website: https://www.molped.com.pk/

WASHINGTON: The US drug regulator on Friday added a warning to the literature that accompanies Pfizer Inc /BioNTech and Moderna Covid vaccine shots to indicate the rare risk of heart inflammation after its use.

For each vaccine, the fact sheets for healthcare providershave been revised toinclude a warning that reports of adverse events suggest increased risks of myocarditis and pericarditis, particularly after the second dose and with onset of symptoms within a few days after vaccination, the FDA said.

As of June 11, more than 1,200 cases of myocarditis or pericarditis have been reported to the US Vaccine Adverse Event Reporting System, out of about 300 million mRNA vaccine doses administered.

The cases appear to be notably higher in males and in the week af ter the second vaccine dose. The CDC identified 309 hospitalisations from heart inflammation in persons under the age of 30, of which 295 have been discharged.

Health regulators in several countries have been investigating cases of myocarditis and pericarditis, more frequently found in young men, after a shot of Pfizer or Moderna, vaccines that are based on the mRNA technology.

The latest update from FDA follows an extensive review of information and the discussion by CDC`s Advisory Committee on Immunisation Practices meeting on Wednesday.